Literature DB >> 9248622

Characterization of in vitro culture of HIV-negative Kaposi's sarcoma-derived cells. In vitro responses to alfa interferon.

C Lebbé1, P de Crémoux, G Millot, M P Podgorniak, O Verola, R Berger, P Morel, F Calvo.   

Abstract

We established long-term cultures from skin tumors of nine patients suffering from classical Kaposi's sarcoma (KS). Spindle cells obtained after enzymatic digestion were cultured on gelatin- or fibronectin-coated flasks in DMEM with 15% fetal calf serum, aFGF and heparin. Immunohistochemical staining was positive for MHC class I, laminin, type IV collagen, vimentin, alpha smooth muscle actin (20-40% of cells), caldesmon (20%), calponin (20-40%) and smooth muscle myosin (20-40%), and was negative for common leukocyte antigen, CD4, LFA1, CD34 and cytokeratin. Around 20% of cells up to the third passage in culture expressed the endothelial markers CD36, BMA 120 but were negative for UEA and Fc von Willebrand. Smooth muscle proteins were detected with immunoblotting. Using the polymerase chain reaction, human herpes virus 8 (HHV8) sequences were detected in primary cultures of three out of seven cell lines but were rapidly lost during in vitro passaging. KS-derived cells did not proliferate in serum-free medium, had a normal karyotype and did not grow in soft agar medium. Tumors formed in nude mice injected with KS-derived cells. The tumors were composed of mouse cells and were highly vascularized. Our results suggest that KS-derived cells are heterogeneous: the majority of cells have either a smooth muscle cell or a fibroblastic phenotype. Another minor cell compartment was composed of endothelium-derived cells. KS cells do not possess the characteristics of transformed cells in vitro and may be composed of polyclonal activated cells. Recombinant alpha interferon (rIFN) slightly inhibited the growth of KS-derived cells and increased the expression of MHC class I antigens. While cells were resistant to natural killer (NK) cell-mediated cytotoxicity, they became sensitive to rIFN-primed NK cells. Thus, the antitumor potential of rIFN against KS in vivo could result from immunomodulatory rather than from direct antiproliferative effects.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9248622     DOI: 10.1007/s004030050215

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  13 in total

1.  Extracellular Hsp90 serves as a co-factor for MAPK activation and latent viral gene expression during de novo infection by KSHV.

Authors:  Zhiqiang Qin; Michael DeFee; Jennifer S Isaacs; Chris Parsons
Journal:  Virology       Date:  2010-05-06       Impact factor: 3.616

2.  Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis.

Authors:  Adam Grundhoff; Don Ganem
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

3.  Direct and efficient cellular transformation of primary rat mesenchymal precursor cells by KSHV.

Authors:  Tiffany Jones; Fengchun Ye; Roble Bedolla; Yufei Huang; Jia Meng; Liwu Qian; Hongyi Pan; Fuchun Zhou; Rosalie Moody; Brent Wagner; Mazen Arar; Shou-Jiang Gao
Journal:  J Clin Invest       Date:  2012-02-01       Impact factor: 14.808

4.  Long-term-infected telomerase-immortalized endothelial cells: a model for Kaposi's sarcoma-associated herpesvirus latency in vitro and in vivo.

Authors:  Feng-Qi An; Hope Merlene Folarin; Nicole Compitello; Justin Roth; Stanton L Gerson; Keith R McCrae; Farnaz D Fakhari; Dirk P Dittmer; Rolf Renne
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

5.  De novo infection and serial transmission of Kaposi's sarcoma-associated herpesvirus in cultured endothelial cells.

Authors:  Michael Lagunoff; Jill Bechtel; Eleni Venetsanakos; Anne-Marie Roy; Nancy Abbey; Brian Herndier; Martin McMahon; Don Ganem
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

6.  Upregulation of xCT by KSHV-encoded microRNAs facilitates KSHV dissemination and persistence in an environment of oxidative stress.

Authors:  Zhiqiang Qin; Eduardo Freitas; Roger Sullivan; Sarumathi Mohan; Rocky Bacelieri; Drake Branch; Margaret Romano; Patricia Kearney; Jim Oates; Karlie Plaisance; Rolf Renne; Johnan Kaleeba; Chris Parsons
Journal:  PLoS Pathog       Date:  2010-01-29       Impact factor: 6.823

7.  Lytic replication-defective Kaposi's sarcoma-associated herpesvirus: potential role in infection and malignant transformation.

Authors:  Jian-Hong Deng; Yan-Jin Zhang; Xin-Ping Wang; Shou-Jiang Gao
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

8.  The product of Kaposi's sarcoma-associated herpesvirus immediate early gene K4.2 regulates immunoglobulin secretion and calcium homeostasis by interacting with and inhibiting pERP1.

Authors:  Lai-Yee Wong; Kevin Brulois; Zsolt Toth; Kyung-Soo Inn; Sun-Hwa Lee; Kathryn O'Brien; Hyera Lee; Shou-Jiang Gao; Ethel Cesarman; Armin Ensser; Jae U Jung
Journal:  J Virol       Date:  2013-08-28       Impact factor: 5.103

Review 9.  Lipids, lipid metabolism and Kaposi's sarcoma-associated herpesvirus pathogenesis.

Authors:  Lu Dai; Zhen Lin; Wei Jiang; Erik K Flemington; Zhiqiang Qin
Journal:  Virol Sin       Date:  2017-10-10       Impact factor: 4.327

10.  KSHV-Encoded MicroRNAs: Lessons for Viral Cancer Pathogenesis and Emerging Concepts.

Authors:  Zhiqiang Qin; Andrew Jakymiw; Victoria Findlay; Chris Parsons
Journal:  Int J Cell Biol       Date:  2012-02-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.